Abstract

In the last decade, reliable scientific evidence has emerged to support the concept that undetectable viral loads prevent human immunodeficiency virus (HIV). Undetectable equals untransmissible (U = U) is a simple message that everyone can understand. The success of this concept depends on strict adherence to antiretroviral therapy (ART) and the attainment of suppressed viral loads (VLs). To achieve U = U in sub-Saharan Africa (SSA), poor adherence to ART, persistent low-level viremia, and the emergence of drug-resistant mutants are challenges that cannot be overlooked. Short of a cure for HIV, U = U can substantially reduce the burden and change the landscape of HIV epidemiology on the continent. From a public health perspective, the U = U concept will reduce stigmatization in persons living with HIV (PLWHIV) in SSA and strengthen public opinion to accept that HIV infection is not a death sentence. This will also promote ART adherence because PLWHIV will aim to achieve U = U within the shortest possible time. This article highlights challenges and barriers to achieving U = U and suggests how to promote the concept to make it beneficial and applicable in SSA. This concept, if expertly packaged by policy-makers, clinicians, health service providers, and HIV control programs, will help to stem the tide of the epidemic in SSA.

Highlights

  • Since the discovery of the human immunodeficiency virus (HIV), the search for effective treatment and cure has occupied the scientific community

  • AZT brought a lifeline to persons living with HIV (PLWHIV) as it reduced the HIV viral loads (VLs) and delayed progression to full-blown AIDS [2,3]

  • The sustained ability of antiretroviral therapy (ART) to keep the VL at undetectable levels has given birth to the concept of undetectable equals untransmissible (U = U). This U = U concept is supported by strong scientific evidence which is showing that consistent undetectable VLs for at least six months may prevent an individual from transmitting HIV sexually [8,9,10]

Read more

Summary

Introduction

Since the discovery of the HIV, the search for effective treatment and cure has occupied the scientific community. The sustained ability of ART to keep the VL at undetectable levels has given birth to the concept of undetectable equals untransmissible (U = U) This U = U concept is supported by strong scientific evidence which is showing that consistent undetectable VLs for at least six months may prevent an individual from transmitting HIV sexually [8,9,10]. Given this strong scientific evidence, there have been massive campaigns to promote strict adherence to “test and treat” regardless of CD4 count [13,14] Following all this evidence, the director of the National Institute of Allergy and Infectious Disease (NIAID), Dr Anthony S.

Low Viral Load and Transmissibility
Transcriptional Silencing
HIV Clinical Practice in Sub-Saharan Africa and Its Challenges
Factors Affecting Adherence to ART in Sub-Saharan Africa
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.